Effectiveness of an EMDR Intervention for Perinatal Loss

Sponsor
Hospital Clinic of Barcelona (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05701137
Collaborator
EMDR Europe (Industry)
40
2
21.9

Study Details

Study Description

Brief Summary

The investigators objectives is to assess the effectiveness of Eye Movement Desensitization and Reprocessing - recent traumatic episode (EMDR-RTE) as a preventive intervention for Posttraumatic Stress Disorder (PTSD) symptoms after perinatal loss.

The hypothesis is that EMDR-RTE treatment may prevent post-traumatic and depressive symptoms in women who suffered perinatal loss.

Condition or Disease Intervention/Treatment Phase
  • Other: EMDR-RTE
  • Other: TAU
N/A

Detailed Description

Perinatal loss is a general term that refers to a loss from conception to one month postpartum. It is a grief that is still socially unauthorized, however, it is a situation with significant traumatic potential. However, there are no studies evaluating the effectiveness of Eye Movement Desensitization and Reprocessing (EMDR) for the prevention or treatment of perinatal loss. We propose an one-site, open label, randomized controlled trial with the aim of assessing the effectiveness of EMDR recent traumatic episode (EMDR-RTE) as a preventive intervention for PTSD symptoms after perinatal loss. A total of 40 women who have suffered a perinatal loss from the Maternal-Fetal Medicine Service of a tertiary university hospital will be recruited. Women will be randomized to EMDR-RTE or treatment as usual (TAU). Researchers will compare EMDR-RTE and TAU to see if women receiving EMDR-RTE treatment had lower levels of post-traumatic and depressive symptoms.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Effectiveness of an Eye Movement Desensitization and Reprocessing (EMDR) Intervention for the Prevention of Post-traumatic Symptoms in Perinatal Loss
Anticipated Study Start Date :
Feb 1, 2023
Anticipated Primary Completion Date :
Sep 30, 2024
Anticipated Study Completion Date :
Nov 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: EMDR-RTE

Eye movement desensitization and reprocessing in its recent traumatic episode version.

Other: EMDR-RTE
The experimental group will have EMDR recent traumatic event.

Active Comparator: TAU

Usual treatment by a psychologist.

Other: TAU
The comparator group will have usual psychological intervention.

Outcome Measures

Primary Outcome Measures

  1. PCL-5 [Within the first month after perinatal loss]

    PTSD Checklist for DSM-5

  2. PCL-5 [3 months after perinatal loss]

    PTSD Checklist for DSM-5

Secondary Outcome Measures

  1. STAI S/T [Within the first month after perinatal loss]

    Spielberger State/Trait Anxiety Inventory

  2. STAI S/T [3 months after perinatal loss]

    Spielberger State/Trait Anxiety Inventory

  3. BDI-II [Within the first month after perinatal loss]

    Beck Depression Inventory

  4. BDI-II [3 months after perinatal loss]

    Beck Depression Inventory

Other Outcome Measures

  1. Satisfaction survey [3 months after perinatal loss]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • be over 18 years old

  • agree to participate and sign the informed consent

  • request psychological treatment

Exclusion Criteria:
  • active substance use disorder

  • cognitive disability

  • language barrier

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Hospital Clinic of Barcelona
  • EMDR Europe

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hospital Clinic of Barcelona
ClinicalTrials.gov Identifier:
NCT05701137
Other Study ID Numbers:
  • 2022-03
First Posted:
Jan 27, 2023
Last Update Posted:
Jan 27, 2023
Last Verified:
Nov 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Hospital Clinic of Barcelona

Study Results

No Results Posted as of Jan 27, 2023